Hogle D M, Smith R S, Curtiss L K
Johnson & Johnson Biotechnology Center, San Diego, CA 92121.
J Lipid Res. 1988 Sep;29(9):1221-9.
A rapid sandwich enzyme-linked immunosorbent assay (ELISA) for the quantitation of human apolipoprotein (apo) A-I was developed. The assay uses a pair of noncompeting purified monoclonal antibodies to detect apoA-I in plasma. The antibodies used in this assay were selected because they bind greater than 90% of radioiodinated high density lipoprotein (HDL), they identify "fresh" nondeamidated epitopes on apoA-I, and they have comparable binding affinities for isolated HDL and HDL in plasma. The assay was standardized with a plasma secondary standard composed of lyophilized human serum. The assay was used to measure the apoA-I levels in normal subjects, patients with coronary artery disease, and patients with familial hypercholesterolemia. The results indicate that certain monoclonal antibodies can be used to reliably measure plasma levels of apoA-I in diverse groups of subjects.
开发了一种用于定量人载脂蛋白(apo)A-I的快速夹心酶联免疫吸附测定(ELISA)法。该测定法使用一对非竞争性纯化单克隆抗体来检测血浆中的apoA-I。选择该测定法中使用的抗体是因为它们能结合超过90%的放射性碘化高密度脂蛋白(HDL),能识别apoA-I上“新鲜的”未脱酰胺表位,并且它们对分离的HDL和血浆中的HDL具有相当的结合亲和力。该测定法用由冻干人血清组成的血浆二级标准品进行标准化。该测定法用于测量正常受试者、冠状动脉疾病患者和家族性高胆固醇血症患者的apoA-I水平。结果表明,某些单克隆抗体可用于可靠地测量不同受试者群体中血浆apoA-I的水平。